After months of hard work, a new milestone in the IMI ConcePTION public-private partnership has been achieved: Elevate has completed the final course design. With that, the start of the next phase – the development of the course materials – is marked and we are one step closer to the launch of an online course for safe medicine use during pregnancy and breastfeeding. In this project, we are happy to collaborate with many partners, such as ENTIS, Sanofi, Novartis and more.
Within Work Package 5 – for the dissemination and education for healthcare professionals, pregnant and breastfeeding women and general public – steps are taken for the development of a self-paced online course. This course will consist of 4 different chapters and is aimed towards general practitioners, midwives, obstetricians and gynaecologists (OB-GYN), and pharmacists.
The course will be expected to launch early 2022. In addition, first steps have been made by the consortium for the development of a sustainability plan for all the deliverables.
Women who are pregnant and the babies they breastfeed, deserve to know if a medicine is safe. The ConcePTION project has a huge and difficult task ahead: building a system for drug safety in pregnancy and breastfeeding. Universities, the pharmaceutical companies that develop medicines, the authorities that approve medicines and monitor safety, women and their doctors need to work together to solve a complicated puzzle: turning data into evidence!
